Email Updates

You are here

Home

Purpose 4/ HPTN 103

Status
Planned
Phase
Open Label
Objective

This study focused on PWID acceptability of LEN is not yet on the record and was announced as planned during HPTN 2022 meeting. 

 

Last updated June 10, 2022

Prevention Option(s)
PrEP
Arms and Assigned Interventions
Products
Lenacapavir
Population
Injecting drug users